siltuximab for the management of car-t toxicities: a multicenter retrospective study
Published 7 months ago • 88 plays • Length 0:50Download video MP4
Download video MP3
Similar videos
-
2:53
safety and efficacy of allogenic car-t cell treatment
-
1:49
a novel subcutaneous car-t therapy for the treatment of hematological malignancies
-
0:57
toxicities after car-t
-
1:37
professional education and training on the management car t-cell toxicities
-
9:58
the management & optimization of car t-cell therapy in myeloma
-
4:10
car t-cell therapy for all
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
2:45
safety and efficacy of inotuzumab ozogamicin conditioning for allosct in lymphoid malignancies
-
1:39
the role of myeloid cells in car-t cell therapy
-
1:19
sequencing bispecific antibodies and car-t therapy & the evolving role of bispecifics in myeloma
-
1:35
key mechanisms of resistance to car t-cell therapy
-
3:21
safety management of car-t cell therapy in dlbcl
-
4:17
preparing for the commercialization of car-t products
-
0:59
the clinical implementation of car t-cell therapy
-
2:14
exploring the potential role of cd7-targeting car-t cells for the treatment of t-all
-
2:17
the role of car t-cell therapy for treating myeloma in the era of bispecific antibodies
-
1:36
education initiatives for car t-cell therapy
-
2:11
exploring strategies to mitigate t-cell exhaustion: treatment-free intervals & small molecules
-
1:18
the role of social media in the development of car-t therapy